Sort   by:  
 Page size 
TranscriptomicsGENOMIC ANALYSIS OF FIBROLAMELLAR HEPATOCELLULAR CARCINOMA REVEALS A UNIQUE MOLECULAR PROFILE
Fibrolamellar hepatocellular carcinoma (FLC) is a rare primary hepatic cancer usually developed in non-cirrhotic livers of children and young adults with unknown etiology. Treatment is limited to surgical intervention. To date, molecular pathogenesis of FLC has been poorly characterized. A cohort of...
ORGANISM(S): Homo sapiens 
2015-02-12 | E-GEOD-59443 | biostudies-arrayexpress
UnknownYeast Monitoring of Wine Mixed or Sequential Fermentations Made by Native Strains from D.O. "Vinos de Madrid" Using Real-Time Quantitative PCR.
Not available
S-EPMC5742323 | biostudies-literature
UnknownTRUFA: A User-Friendly Web Server for de novo RNA-seq Analysis Using Cluster Computing.
Not available
S-EPMC4444131 | biostudies-literature
UnknownA Sex-Specific Minimal CpG-Based Model for Biological Aging Using <i>ELOVL2</i> Methylation Analysis.
Not available
S-EPMC11989821 | biostudies-literature
UnknownPhysiologically based mathematical models of nanomaterials for regulatory toxicology: A review.
Not available
S-EPMC6472634 | biostudies-literature
UnknownComputational models for the assessment of manufactured nanomaterials: Development of model reporting standards and mapping of the model landscape.
Not available
S-EPMC6472618 | biostudies-literature
UnknownHigher Loading of Gold Nanoparticles in PAD Mesenchymal-like Stromal Cells Leads to a Decreased Exocytosis.
Not available
S-EPMC9367297 | biostudies-literature
UnknownRisk factors for surgical site infection after craniotomy: a prospective cohort study.
Not available
S-EPMC6498621 | biostudies-literature
UnknownOverexpression of microRNAs miR-25-3p, miR-185-5p and miR-132-3p in Late Onset Fetal Growth Restriction, Validation of Results and Study of the Biochemical Pathways Involved.
Not available
S-EPMC8745308 | biostudies-literature
TranscriptomicsTUMOR INITIATING CELLS AND IGF/FGF SIGNALING CONTRIBUTE TO SORAFENIB RESISTANCE IN HEPATOCELLULAR CARCINOMA
OBJECTIVE: Sorafenib is effective in hepatocellular carcinoma (HCC), but patients ultimately present disease progression. Molecular mechanisms underlying acquired resistance are still unknown. Herein, we characterize the role of tumor-initiating cells (T-ICs) and signaling pathways involved in soraf...
ORGANISM(S): Homo sapiens 
2016-06-16 | E-GEOD-73571 | biostudies-arrayexpress
Sort   by:  
 Page size